Noticias de CLLS_US

Noticias del mercado

Últimas noticias sobre CLLS_US — 156 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CLLS_US ✕ 156 resultados
01/05/2026 CLLS_US — Intellectia AI
CLLS.O Technical Analysis & Stock Price Forecast

Obtenga análisis técnico CLLS.O en tiempo real, promedios móviles, indicadores RSI y MACD. Vea pronósticos de acciones profesionales y señales de compra/venta.

30/04/2026 CLLS_US — MarketBeat
Cellectis (NASDAQ:CLLS) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?
29/04/2026 CLLS_US — MSN
MSN Money
27/04/2026 CLLS_US — Stock Titan
Cellectis (NASDAQ: CLLS) showcases TALEM epigenetic gene-silencing platform
27/04/2026 CLLS_US — TipRanks
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
27/04/2026 CLLS_US — Stock Titan
Cellectis shows a way to switch off genes without cutting DNA
22/04/2026 CLLS_US — MarketBeat
Cellectis (NASDAQ:CLLS) Shares Pass Below 200-Day Moving Average - Time to Sell?
18/04/2026 CLLS_US — Intellectia AI
CLLS Should I Buy
18/04/2026 CLLS_US — Intellectia AI
CLLS.O Stock News Today | Earnings, Events & Price Alerts
14/04/2026 CLLS_US — Investing.com
Cellectis stock rating held at outperform on allogeneic platform
14/04/2026 CLLS_US — GuruFocus
CLLS Reiterated by Citizens -- Price Target Maintained at $8.00
13/04/2026 CLLS_US — Stock Titan
Cema-cel data lift Cellectis (NASDAQ: CLLS) allogeneic CAR-T ambitions
13/04/2026 CLLS_US — TipRanks
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
13/04/2026 CLLS_US — MarketScreener
Cema-cel pivotal trial interim data highlight strength of Cellectis' allogeneic CAR-T platform
13/04/2026 CLLS_US — Stock Titan
Most patients stayed outpatient as cema-cel hit 58.3% MRD negativity
13/04/2026 CLLS_US — Benzinga
Leggett & Platt, Allogene Therapeutics, Revolution Medicines And Other Big Stocks Moving Higher On Monday
13/04/2026 CLLS_US — MarketScreener
Cellectis Highlights Interim Data of Cema-Cel Pivotal Trial
13/04/2026 CLLS_US — TipRanks
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
13/04/2026 CLLS_US — Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
09/04/2026 CLLS_US — Newser
Is Cellectis (CLLS) Stock Stable Now | Price at $3.45, Down 2.82% - Expert Momentum Signals

Página 6 de 8

keyboard_arrow_up